Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Immunization in Clinical Practice
Nitin K Shah, Naveen C Thacker, Abhay K Shah, Alok Gupta
SECTION I: BASICS IN IMMUNIZATION
CHAPTER 1:
General Immunology and Principles of Vaccination
INTRODUCTION
IMMUNE SYSTEM
TYPES OF IMMUNITY
Non-specific Immunity
Specific Immunity
HUMORAL IMMUNE RESPONSE
ANTIGEN-PRESENTING CELLS
CELL-MEDIATED IMMUNITY
ROLE OF VARIOUS TYPES OF IMMUNE RESPONSES IN INFECTIONS
Primary vs. Secondary Immune Response
T-cell-dependent Immune Response
PASSIVE IMMUNITY
Transplacental Passive Immunity
Acquired Passive Immunity
Pooled Human Immunoglobulins
Homologous Human Hyperimmune Globulins
Heterologous Human Hyperimmune Globulins
ACTIVE IMMUNITY
VACCINES
Live Vaccines
Inactivated Vaccines
IMMUNE MEMORY
IMMUNOMODULATION
CHAPTER 2:
General Guidelines for Vaccination
INTRODUCTION
STAFF EDUCATION
PATIENT PREPARATION AND CARE
VACCINE PREPARATION
Equipment Selection
Inspecting Vaccine
Reconstitution
VACCINE ADMINISTRATION (TABLES 2.1 TO 2.4)
Route and Site
Nonstandard Administration
IMMUNIZATION IN SPECIAL SITUATIONS
Simultaneous Administration of Two or More Vaccines
Vaccinating Persons with Bleeding Disorders
Immunization and Blood Products
Interchange of a Brand
DOCUMENTATION
VACCINE STORAGE AND HANDLING
SAFE INJECTION PRACTICES AND INFECTION CONTROL
Safe Disposal of Injection Equipment
ADVERSE EVENTS FOLLOWING IMMUNIZATION
Common Minor Vaccine Reactions
CONCLUSION
CHAPTER 3:
Immunization Schedules
INTRODUCTION
PRINCIPLES OF VACCINE SCHEDULING
NATURE OF VACCINE
IMMUNOGENICITY AND POTENTIAL INTERFERENCE BY PASSIVELY TRANSFERRED MATERNAL ANTIBODIES
LOCAL EPIDEMIOLOGY OF THE DISEASE
CHANGING EPIDEMIOLOGY OF THE DISEASE
SPACING OF MULTIPLE DOSES OF THE SAME ANTIGEN
SIMULTANEOUS ADMINISTRATION OF VACCINES
COMBINATION VACCINES
VACCINE FAILURE
DEVELOPING AND DEVELOPED COUNTRIES
UPDATING THE SUBJECT
PRACTICAL TRAINING
WHO AND IMMUNIZATION PROGRAMS
NATIONAL IMMUNIZATION SCHEDULE
IAP IMMUNIZATION SCHEDULE
INTERNATIONAL IMMUNIZATION SCHEDULES
IMMUNIZATION IN ADOLESCENTS
IMMUNIZATION SCHEDULE FOR AN UNIMMUNIZED CHILD
CHAPTER 4:
Storage of Vaccines and Maintenance of Cold Chain
INTRODUCTION
WHY SHOULD WE BE CONCERNED ABOUT PROPER VACCINE STORAGE?
COLD CHAIN
STORAGE OF VACCINES
Heat and Freeze Sensitivity of Vaccines
Sensitivity to Light
Recommended Storage Temperature
Correct Storing Condition for Diluents
LEVELS OF VACCINE STORAGE
National Level
Regional Level
District Level
Health Facility Level
COLD BOXES (COOLERS)
VACCINE CARRIERS
CONDITIONING OF ICE PACKS
TIPS FOR BETTER VACCINE STORAGE IN DOMESTIC REFRIGERATORS
Placement of Refrigerator
Recognize Individual Vaccine Refrigerator
Stabilize the Temperature of the Refrigerator before Stocking
Monitoring Temperatures Inside the Refrigerator
Safeguard the Power Source
Increase Cool Mass
Storage Method
Keep the Door Closed as Much as Possible
Maintenance of the Vaccine Refrigerator
Power Failure
Refrigerator Failure
PURPOSE-BUILT VACCINE REFRIGERATOR
Voltage Control
COLD CHAIN TEMPERATURE MONITORING
Monitoring of Temperatures
Standard Fluid Filled
Dial
Digital
Continuous Reading
Data Loggers
Vaccine Vial Monitor
Safeguard of Vaccines During Immunization Session
PERSONNEL
PROTOCOLS
CHAPTER 5:
Adverse Events Following Immunization
INTRODUCTION
VACCINE REACTIONS
Vaccine Reactions by Severity and Frequency
Common, Minor Vaccine Reactions
Serious and Severe Vaccine Reactions
REPORTING AND INVESTIGATIONS
Management of Anaphylaxis
Role of Pediatricians in AEFI Surveillance
How to Report AEFI from Private Sector
Online AEFI Reporting Platform for Private Practitioners
CAUSALITY ASSESSMENT
Adequate Information Available
Consistent Causal Association to Immunization (A)
Indeterminate (B)
Inconsistent Causal Association to Immunization (Coincidental) (C)
Adequate Information not Available (Unclassifiable)
CHAPTER 6:
Safe Injection Practices
INTRODUCTION
WHAT IS AN INJECTION?
WHAT IS A SAFE INJECTION?
WHY ARE INJECTIONS SO POPULAR?
MAGNITUDE OF THE PROBLEM
WHAT CAN BE DONE TO PROMOTE SAFE AND APPROPRIATE USE OF INJECTIONS?
RECOMMENDED ROUTES OF INJECTION AND NEEDLE LENGTH
Intradermal Injections
Subcutaneous Injections
Intramuscular Injections
Multiple Vaccinations
INJECTION DEVICES
Disposable Plastic Syringes and Needles
Auto-Disable Syringes
Jet Injectors
WHAT IS THE PROGRESS?
INJECTION SAFETY GUIDELINES
WASTE DISPOSAL
SECTION II: VACCINES WIDELY USED IN CHILDREN
CHAPTER 7:
Immunization Against Tuberculosis
INTRODUCTION
EPIDEMIOLOGY OF TUBERCULOSIS
Pathogen
Pathogenesis
PREVENTION OF THE DISEASE
Immunity against Tuberculosis
BCG VACCINATION
History
Types of Vaccine
Storage
Reconstitution
Dosage
Administration
Phenomena Seen after BCG Vaccination
Complications with Intradermal BCG16
Contraindications to BCG Vaccination
BCG Vaccination and the Mantoux Test
Age of BCG Vaccination
Efficacy of BCG Vaccination
REVACCINATION
BCG Immunization and HIV
Other Uses of BCG
Combined Vaccination
NEWER VACCINES FOR TUBERCULOSIS
Current Status
Preclinical Development of New TB Vaccines
Virus-Vectored Vaccines
Electroporated DNA Vaccination
Heparin-Binding Hemaglutinin
Clinical Development of New TB Vaccines
CONCLUSION
CHAPTER 8:
Diphtheria, Pertussis and Tetanus Vaccines
EPIDEMIOLOGY
Diphtheria
Pertussis
Tetanus
DIPHTHERIA, PERTUSSIS AND TETANUS (DPT) VACCINES
DTwP Vaccine
Immunogenicity and Efficacy
Duration of Protection
Adverse Effects
Contraindications and Precautions
DTaP Vaccines
Efficacy
Duration of Protection
Adverse Effects
Contraindications and Precautions
Tetanus, Reduced Antigen of Diphtheria and Acellular Pertussis (Tdap) Vaccines
Efficacy and Effectiveness
Adverse Effects
Precautions and Contraindications
IAP Recommendations for Use of DTP/TdaP Vaccines15
Routine Vaccination
Vaccination in Specific Circumstances
CHAPTER 9:
Immunization Against Poliomyelitis
INTRODUCTION
PATHOGEN
HOST
MODE OF TRANSMISSION
MORBIDITY INCLUDING CLINICAL SPECTRUM
DISEASE MORTALITY
VACCINES AGAINST POLIOMYELITIS
Inactivated Polio Vaccine
Oral Polio Vaccine
Immunogenicity of IPV and OPV
Definitions of Immunogenicity and Mucosal Immunity
Immunogenicity of IPV
Immunogenicity of OPV
VACCINE EFFICACY
COMBINATION VACCINES
VACCINE SCHEDULE
VACCINE STORAGE, HANDLING AND INOCULATION
ADVERSE REACTIONS FOLLOWING VACCINATION
CONTRAINDICATIONS
SPECIAL CONSIDERATIONS
CHAPTER 10:
Immunization Against Measles, Mumps and Rubella
INTRODUCTION
CLINICAL FEATURES
EFFECT ON IMMUNITY
COMPLICATIONS
VIROLOGY
EPIDEMIOLOGY
PASSIVE IMMUNIZATION
ACTIVE IMMUNIZATION
VACCINE STRAINS
VACCINE COMPOSITION
DOSAGE AND ROUTE OF ADMINISTRATION
STABILITY OF VACCINE
Combination with Rubella, Mumps, and Varicella Vaccines
RESULTS OF VACCINATION
Immune Response
Response to Revaccination
EFFECTIVENESS OF PROTECTION
Measures of Protection
Host Factors Affecting Protection
Maternal Antibody and Age at Vaccination
Intercurrent Illness and Malnutrition
Vitamin A Supplementation
WHO Recommendation
Persistence of Immunity
Combined Vaccines and Simultaneous Vaccination
Postexposure Prophylaxis
Use of Vaccine
Use of Immuneoglobulin
Adverse Effects
Indications, Timing of Vaccination, Precautions and Contraindications
Recommendation by IAP-ACVIP (Indian Academy of Pediatrics: Advisory Committee on Vaccination and Immunization Practices)
Future Vaccines
Public Health Considerations
Measles Eradication
Indian Perspective
India's Decision to Introduce MCV2
CLINICAL FEATURES
Acquired Rubella
Congenital Rubella Syndrome
VIROLOGY
Pathogenesis as it Relates to Prevention
EPIDEMIOLOGY
SIGNIFICANCE AS A PUBLIC HEALTH PROBLEM
INDIAN DATA
PASSIVE IMMUNIZATION
Ordinary Immune Serum Globulin
ACTIVE IMMUNIZATION
VACCINE STRAINS
DOSAGE AND ROUTE OF ADMINISTRATION
STABILITY OF VACCINE
COMBINATION WITH MEASLES AND MUMPS
RESULTS OF VACCINATION
Immune Responses
Rubella in the MMR Combination
Effect of Maternal Antibody
Protective Effects
Correlates of Immunity
Reinfection and Herd Immunity
Persistence of Immunity and Revaccination
Combined and Associated Vaccines
Adverse Reactions
Indications for Rubella Vaccine
Infants
Adolescents
College Students
Hospital Employees
International Travelers
Contraindications
Public Health Considerations
India
Strategies for Rubella Vaccination
Paradoxical Increase in CRS
CLINICAL FEATURES
Complications are more Frequent in Adults than Children
VIROLOGY
EPIDEMIOLOGY
PASSIVE IMMUNIZATION
ACTIVE IMMUNIZATION
VACCINE STRAINS
DOSAGE, ROUTE OF ADMINISTRATION AND COMPOSITION
STABILITY OF VACCINE
COMBINATIONS INCLUDING MUMPS VACCINE
VACCINE USE
CORRELATES OF IMMUNITY
PERSISTENCE OF ANTIBODIES
PROTECTIVE EFFICACY AND EFFECTIVENESS
SIMULTANEOUS ADMINISTRATION WITH OTHER VACCINES
ADVERSE EVENTS
Aseptic Meningitis
Leningrad-Zagreb
Urabe AM9
Jeryl Lynn
PRECAUTIONS AND CONTRAINDICATIONS
EPIDEMIOLOGIC EFFECTS OF VACCINATION
INDIAN PERSPECTIVE ON MMR VACCINE
CHAPTER 11:
Immunization Against Hepatitis B
INTRODUCTION
EPIDEMIOLOGY
HEPATITIS B—TRANSMISSION
Perinatal Transmission
Prevalence of HBsAg in Pregnancy—Risk of Neonatal Transmission
Maternal “e” Antigenemia—An Additional Risk for Neonatal Transmission
Transplacental or Intrauterine Transmission
Others
PREVENTION OF HEPATITIS B
Passive Protection—HBIg (Hepatitis B Immunoglobulin)
Active Immunization—HBV (Hepatitis B Vaccine)
Types of Vaccines
Plasma-derived HBV Vaccines
Recombinant DNA Hepatitis B Vaccines
Combination Vaccines
Future Vaccines
Therapeutic Vaccines
Vaccine Dosage and Route of Administration
Vaccine Immunogenicity and Schedules
Vaccination Schedule in Infants
Vaccination Schedule in Adolescents
Vaccination Schedule in Adults
Hemodialysis Patients
Other Immunocompromised Persons
VACCINE EFFICACY
Pre-exposure Vaccine Efficacy
Postexposure Vaccine Efficacy
ADVERSE EVENTS
CONTRAINDICATIONS TO VACCINATION
VACCINE ESCAPE MUTANTS
RECOMMENDATIONS FOR VACCINATION
IAPCOI Recommendations for Hep B Vaccination108
Routine Vaccination
Catch Up Vaccination
WORLD HEALTH ORGANIZATION (WHO) RECOMMENDATIONS
Postexposure Prophylaxis to Prevent Hepatitis B Infection
Prevention of Perinatal HBV Infection
People with Accidental Percutaneous/Permucosal Exposure to Blood
PUBLIC HEALTH IMPORTANCE OF HEPATITIS B VACCINATION
Importance of Birth Dose
Effectiveness of Routine Infant Hepatitis B Immunization
CONCLUSION
CHAPTER 12:
Immunization Against Typhoid Fever
INTRODUCTION
BURDEN OF DISEASE
Global
Asia and the Indian Subcontinent
Age Distribution
Seasonality
Paratyphoid Fever
IDsurv Data
Epidemiology
Causative Agent
Host
Mode of Transmission
Clinical Presentation
Drug Resistance
Prevention of Disease
Vaccines Against Typhoid Fever
Whole-cell Inactivated Typhoid/Paratyphoid
New Generation Typhoid Vaccines
Live, Oral Ty21a Vaccine
Injectable Typhoid Vaccines
Vi-PS Conjugate Vaccine Conjugated with Pseudomonas aeruginosa Exotoxin A
Vi-PS Conjugate Vaccine Conjugated with Tetanus Toxoid (Pedatyph®) by Bio-Med Pvt Ltd
Vi-polysaccharide Conjugate Vaccine Conjugated with Tetanus Toxoid from Bharat Biotech (Typbar-TCV®)
Immunogenicity Results
Long-term Immunogenicity
Safety Issues
Serologic Correlates of Protection
Recommendations for Use
Individual Use
WHO Position Paper
CONCLUSION
CHAPTER 13:
Immunization Against Haemophilus influenzae Type B
INTRODUCTION
DISEASE SPECTRUM
DISEASE TRANSMISSION
PREVENTION OF HIB DISEASE
HIB VACCINE
Efficacy and Effectiveness
Interchangeability of Hib Vaccines
Hib Combination Vaccines
Advantages of Combination Vaccines
Benefits to the Recipient and the Family
Benefits to the Healthcare Provider
Hib Vaccination Schedule
Booster Dose for Hib Vaccine
CHAPTER 14:
Immunization Against Hepatitis A
INTRODUCTION
EPIDEMIOLOGY
CLINICAL MANIFESTATIONS
PASSIVE IMMUNIZATION
Pre- and Post-exposure Prophylaxis
ACTIVE IMMUNIZATION
Storage
Route of Administration, Dose and Schedule
Correlates of Protection
Immunogenicity and Persistence of Antibodies
Safety
Efficacy and Effectiveness of HAV Vaccines
Single Dose Vaccination Schedule with Inactivated HAV Vaccine
World Health Organization Recommendations
IAP Recommendations
CHAPTER 15:
Varicella Vaccine
BACKGROUND
EPIDEMIOLOGY
MODE OF TRANSMISSION
CLINICAL SPECTRUM AND OUTCOME
PREVENTION OF VARICELLA
Natural Immunity2
Vaccine
Immunogenicity1,2
Efficacy1,2
Vaccine Storage and Handling1
Site/Method of Vaccination
Administration with Other Vaccines
Adverse Events Following Vaccination1,2,8
Contraindications for Use of the Vaccine1
Precautions for Use of the Vaccine1,2
RECOMMENDATIONS FOR USE
VACCINATION IN SPECIAL SITUATIONS
PASSIVE PROTECTION WITH VARICELLA ZOSTER IMMUNOGLOBULIN (VZIG)1,11,12
FUTURE
CHAPTER 16:
Rotavirus Vaccines
DISEASE BURDEN
VIRUS
ROTAVIRUS VACCINES
IMPACT OF ROTAVIRUS VACCINES15
SEROTYPE REPLACEMENT17
VACCINE SAFETY18
ROTAVAC: THE 116E ORAL ROTAVIRUS VACCINE20,21
ECONOMIC BURDEN OF ROTAVIRUS AND COST-EFFECTIVENESS OF A NATIONAL ROTAVIRUS VACCINATION PROGRAM24
CONCLUSION
CHAPTER 17:
Influenza Vaccines: Current Perspectives
INTRODUCTION
GLOBAL INFLUENZA DISEASE BURDEN
BURDEN OF INFLUENZA DISEASE IN INDIA
INFLUENZA DISEASE SURVEILLANCE IN INDIA
INFLUENZA VACCINES
Vaccine Schedule
Dosage and Methods of Administration?
Intramuscular Vaccine
Intradermal Vaccine
Live Attenuated (Intranasal) Vaccine
Vaccine Efficacy and Effectiveness
VACCINE IMMUNOGENICITY
ADVERSE EVENTS
CONTRAINDICATIONS AND PRECAUTIONS
Children who should not be Vaccinated with IIV
Children who should not be Vaccinated with LAIV
IAP RECOMMENDATIONS 2014
RECENT PANDEMIC IN 2014
VACCINATION TIMING IN INDIA
RECOMMENDED VACCINE STRAINS FOR 2015–2016
CHAPTER 18:
Human Papilloma Virus (HPV) Vaccines
BACKGROUND
BURDEN OF DISEASE CAUSED BY HPV
Global
Cervical Cancer Morbidity and Mortality in India
PREVENTION OF CERVICAL CANCER: SCREENING OR VACCINATION
PATHOGENESIS
PROTECTIVE IMMUNITY
HPV VACCINES
QUADRIVALENT VACCINE (HPV4)
BIVALENT VACCINE (HPV2)
EFFICACY AGAINST GENITAL WARTS
Cross-protection Against Nonvaccine Serotypes
SAFETY OF HPV VACCINES
RECOMMENDATIONS FOR USE
DOSE AND SCHEDULE
CATCH-UP VACCINATION
EVIDENCE AND JUSTIFICATION
CHAPTER 19:
Immunization Against Streptococcus pneumoniae
INTRODUCTION
EPIDEMIOLOGY
Pathogen
Host
Mode of Transmission
DISEASE MORBIDITY INCLUDING CLINICAL SPECTRUM
DISEASE MORTALITY
DRUG RESISTANCE
PREVENTION OF DISEASE
Natural Immunity
Vaccine
Pneumococcal Polysaccharide Vaccine
Limitations of Pneumococcal Polysaccharide Vaccine
Pneumococcal Conjugate Vaccines (PCV)
13 Valent Pneumococcal Conjugate Vaccine (PCV13)
10 Valent Pneumococcal Conjugate Vaccine (PCV10)
Polysaccharide Vaccines Versus Conjugate Vaccines
Immunogenicity and Efficacy
Duration of Protection
Epidemiological Impact
Indications and Schedule
Side Effects
Indian and South Asian Scenario
SECTION III: IMMUNIZATION IN SPECIAL CIRCUMSTANCES
CHAPTER 20:
Dengue Vaccine
INTRODUCTION
PREVENTION
TRIALS FOR VACCINE
ACKNOWLEDGMENTS AND DISCLOSURES
CHAPTER 21:
Immunization of Children in Special Situations
INTRODUCTION
PRETERM AND LOW-BIRTH-WEIGHT INFANTS
MISSED IMMUNIZATION
Child with Uncertain Immunization Status
Child with Lapsed Immunization
ADOLESCENT IMMUNIZATION
ADOPTED CHILD
CHILDREN RESIDING IN INSTITUTIONS
CHILDREN RESIDING IN REFUGEE CAMPS
IMMUNOSUPPRESSED CHILD
Basic Principles for Immunizing the Immunocompromised Child
Specific Considerations in Each Disease
HIV Infection
IMMUNIZATION TO CHILDREN ON STEROID THERAPY
IMMUNIZATION IN CHILDREN WITH MALIGNANCY
IMMUNIZATION IN TRANSPLANT RECIPIENTS
Hemapoietic Stem Cell Transplantation
Solid Organ Transplant
IMMUNIZATION IN ASPLENIC CHILDREN
IMMUNIZATION IN THE CHILD WITH COAGULOPATHY
IMMUNIZATION IN CHILDREN WITH PROGRESSIVE NEUROLOGICAL DISORDER
FOREIGN TRAVEL
Child Going Out of India
Child Coming to India
POSTEXPOSURE VACCINATION
IMMUNIZATION DURING EPIDEMICS
CHAPTER 22:
Immunization Against Neisseria meningitidis
INTRODUCTION
BACTERIOLOGY
RISK FACTORS
PATHOGENESIS
CLINICAL DISEASE AND PRESENTATION
IMMUNITY TO MENINGOCOCCAL DISEASE
ACTIVE IMMUNIZATION
HISTORY OF MENINGOCOCCAL VACCINE DEVELOPMENT
Meningococcal A Conjugate Vaccine
Meningococcal B Conjugate Vaccine
Vaccines against Groups A, C, Y, and W135 Meningococci
Tetravalent Conjugate Vaccine
CHAPTER 23:
Immunization Against Rabies
INTRODUCTION
EPIDEMIOLOGY
Bat Rabies8
VIRUS
Rabies-like Virus and Rabies Related Virus8
PATHOGENICITY
RESERVOIR
MODES OF TRANSMISSION
CLINICAL PRESENTATION OF RABIES IN HUMAN
Incubation Period
Clinical Forms
PREVENTION OF RABIES
RABIES IMMUNOGLOBULIN
Choice of RIG
Failure of RIG Treatment
ANTIRABIES VACCINES9
Duck Embryo Vaccine
Immunogenicity
Modern Tissue Culture Vaccine (MTCV)
Vaccine Strains in Use
Three Types of MTCV are Available in India
Schedules of Vaccinations against Rabies
Essen Protocol
Zagreb Protocol
Intradermal Schedules
Revaccination for Fresh Exposures in Previously Vaccinated Persons
Pre-exposure Vaccination
Adverse Reactions of MTCV
Is it Possible to Include Rabies Vaccines in EPI Schedule
CHAPTER 24:
Immunization Against Japanese Encephalitis
INTRODUCTION
GEOGRAPHY
DISEASE BURDEN
EPIDEMIOLOGY
JAPANESE ENCEPHALITIS VIRUS
CLINICAL PRESENTATION OF JAPANESE ENCEPHALITIS
TREATMENT AND MANAGEMENT
IMMUNITY
LABORATORY INVESTIGATIONS
CASE CLASSIFICATION OF SUSPECTED JAPANESE ENCEPHALITIS
JAPANESE ENCEPHALITIS CONTROL
JAPANESE ENCEPHALITIS VACCINES1
Inactivated Vero Cell-derived Vaccines
Live Attenuated Vaccines
Live Recombinant Vaccines
Safety Profile of Japanese Encephalitis Vaccines
Co-administration with Other Vaccines
VACCINE INTERCHANGEABILITY
JAPANESE ENCEPHALITIS VACCINATION IN SPECIAL RISK GROUPS
IMPACT OF JAPANESE ENCEPHALITIS VACCINES
WHO RECOMMENDATIONS ON JAPANESE ENCEPHALITIS VACCINES
Doses and Age Schedule
Choice of Vaccines
REACTIVE VACCINATIONS DURING OUTBREAKS
JAPANESE ENCEPHALITIS VACCINATION FOR SPECIAL RISK GROUPS
Immunocompromised Persons
Pregnant and Lactating Women
Health-care Workers
Travelers
JAPANESE ENCEPHALITIS VACCINATION PROGRAM IN INDIA
ACKNOWLEDGEMENT
CHAPTER 25:
Immunization of Adolescents
IMPORTANCE OF ADOLESCENT IMMUNIZATION
ADOLESCENT IMMUNIZATION SCHEDULE
HUMAN PAPILLOMAVIRUS VACCINES
Routine Vaccination
Catch-up Vaccination
TETANUS AND DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS (TDAP) VACCINE
Routine Vaccination
Catch-up Vaccination
CATCH-UP VACCINATIONS
Measles, Mumps, and Rubella Vaccine
Varicella Vaccine
Hepatitis B (Hep B) Vaccines
Hepatitis A (Hep A) Vaccines
Typhoid Vaccines
VACCINES IN SPECIAL CIRCUMSTANCES
Influenza Vaccine
Japanese Encephalitis Vaccine
Pneumococcal Vaccines
Meningococcal Vaccines
Rabies Vaccines
Cholera Vaccines
VACCINES FOR ADOLESCENT TRAVELLERS
VACCINES FOR PREGNANT ADOLESCENTS
BARRIERS TO ADOLESCENT IMMUNIZATION
Parents
Adolescents
Health Care Providers
National Health Policy
Overcoming Barriers to Adolescent Immunization
PRACTICE POINTS FOR ADOLESCENT VACCINATION
CONCLUSION
SECTION IV: FUTURE IN VACCINOLOGY
CHAPTER 26:
Combination Vaccines
WHAT IS A COMBINATION VACCINE?
Types
WHY COMBINATION VACCINES?
EFFICACY OF COMBINATION VACCINES
SAFETY OF COMBINATION VACCINES
WHICH COMBINATION VACCINE AVAILABLE?
Advantages of Combination Vaccines
Disadvantages Combination Vaccines
ISSUES WITH COMBINATION VACCINES?
CHAPTER 27:
New Technologies and Future Vaccines
INTRODUCTION
EVOLUTION OF VACCINE TECHNOLOGIES
Change in Paradigm from isolate-inactivate-inject to Discover-Validate-characterize-inject Based Approaches
Systems Approach to Vaccinology
Proteomics
Conjugation
Recombinant Proteins
Synthetic Peptides
Viral Vectors
DNA Vaccines
Adjuvants
Potential New Vaccines
HIV
Malaria
Tuberculosis
Rotavirus Vaccines
Dengue
Respiratory Syncytial Virus
Meningococcal Meningitis
Cancer
Combination Vaccines
Pertussis, Diphtheria, Tetanus Combinations
DTaP-based Combinations
Combination with IPV
Combination with Hib Conjugate Vaccine
Combination with HB
New Combinations
CONCLUSION
CHAPTER 28:
Newer Vaccine Delivery Systems and Newer Technologies for Vaccine Delivery
NEWER VACCINE DELIVERY SYSTEMS
Bacterial Polysaccharide Conjugate Vaccines
Transcutaneous Immunization
Bacterial Ghosts
Novel Adjuvants
Liposomes
Virosomes
ISCOMS (Immune-stimulating Complexes)
Microspheres
CpG Motifs in Vaccination
Cholera Toxin (CT) and E. coli Lymphotoxin (LT)
Bacterial Adhesions
Live Attenuated Bacterial Vectors
BCG
DNA Vaccines
Viral Vaccine Vectors
Edible Vaccines
MF 59
Exosomes
Lipid-Core-Peptide System
NEWER TECHNOLOGIES FOR VACCINE DELIVERY
Auto Disable Syringes and Safety Boxes: UNICEF-WHO Policy
Point of Use Sharps Processing
Monodose Prefilled Injection Devices
Needle-free Injections
Thermostable Vaccines and Vaccine Vial Monitors
CHAPTER 29:
Immunization Resources on Internet
CHAPTER 30:
VPD Surveillance and Integrated Disease Surveillance
BACKGROUND
WHY VPD SURVEILLANCE IS NECESSARY
SURVEILLANCE: TERMINOLOGIES
CURRENT STATUS OF VPD SURVEILLANCE IN INDIA
VPD Surveillance Systems in India
WORLD HEALTH ORGANIZATION—NATIONAL POLIO SURVEILLANCE PROJECT SUPPORTED SURVEILLANCE SYSTEMS
IDSURV-AN INNOVATIVE PROJECT TO REPORT INFECTIOUS DISEASES
Background
Objectives
Infectious Diseases Covered Under IDsurv Project
How to Join IDsurv Network?
How to Report a New Infectious Disease Case?
Serious Adverse Event Following Immunization (AEFI) Surveillance on IDsurv
Current Status of IDSurv
CONCLUSIONS AND THE NEED OF THE HOUR
INDEX
TOC
Index
×
Chapter Notes
Save
Clear